These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20197544)

  • 1. Polycomb group proteins as epigenetic mediators of neuroprotection in ischemic tolerance.
    Stapels M; Piper C; Yang T; Li M; Stowell C; Xiong ZG; Saugstad J; Simon RP; Geromanos S; Langridge J; Lan JQ; Zhou A
    Sci Signal; 2010 Mar; 3(111):ra15. PubMed ID: 20197544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1.
    Voncken JW; Niessen H; Neufeld B; Rennefahrt U; Dahlmans V; Kubben N; Holzer B; Ludwig S; Rapp UR
    J Biol Chem; 2005 Feb; 280(7):5178-87. PubMed ID: 15563468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity.
    Satijn DP; Otte AP
    Mol Cell Biol; 1999 Jan; 19(1):57-68. PubMed ID: 9858531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
    Balasubramanian S; Adhikary G; Eckert RL
    Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation.
    Lessard J; Schumacher A; Thorsteinsdottir U; van Lohuizen M; Magnuson T; Sauvageau G
    Genes Dev; 1999 Oct; 13(20):2691-703. PubMed ID: 10541555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal expression of Bmi1 and Mel-18 is associated with functioning of primitive hematopoietic cells.
    Kajiume T; Ohno N; Sera Y; Kawahara Y; Yuge L; Kobayashi M
    Exp Hematol; 2009 Jul; 37(7):857-866.e2. PubMed ID: 19409954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel member of murine Polycomb-group proteins, Sex comb on midleg homolog protein, is highly conserved, and interacts with RAE28/mph1 in vitro.
    Tomotsune D; Takihara Y; Berger J; Duhl D; Joo S; Kyba M; Shirai M; Ohta H; Matsuda Y; Honda BM; Simon J; Shimada K; Brock HW; Randazzo F
    Differentiation; 1999 Dec; 65(4):229-39. PubMed ID: 10653359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.
    Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M; Facchino S; Chatoo W; Balasingam V; Ferreira J; Bernier G
    J Neurosci; 2009 Jul; 29(28):8884-96. PubMed ID: 19605626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id1 enhances RING1b E3 ubiquitin ligase activity through the Mel-18/Bmi-1 polycomb group complex.
    Qian T; Lee JY; Park JH; Kim HJ; Kong G
    Oncogene; 2010 Oct; 29(43):5818-27. PubMed ID: 20697353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress.
    Ryland KE; Svoboda LK; Vesely ED; McIntyre JC; Zhang L; Martens JR; Lawlor ER
    Oncogene; 2015 Aug; 34(35):4591-600. PubMed ID: 25435365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T; Miyagi S; Saraya A; Aoki R; Seki A; Morita Y; Yonemitsu Y; Yokosuka O; Taniguchi H; Nakauchi H; Iwama A
    Cancer Res; 2008 Oct; 68(19):7742-9. PubMed ID: 18829528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.
    Bárdos JI; Saurin AJ; Tissot C; Duprez E; Freemont PS
    J Biol Chem; 2000 Sep; 275(37):28785-92. PubMed ID: 10825164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.
    Sewalt RG; van der Vlag J; Gunster MJ; Hamer KM; den Blaauwen JL; Satijn DP; Hendrix T; van Driel R; Otte AP
    Mol Cell Biol; 1998 Jun; 18(6):3586-95. PubMed ID: 9584199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic preconditioning alters the epigenetic profile of the brain from ischemic intolerance to ischemic tolerance.
    Thompson JW; Dave KR; Young JI; Perez-Pinzon MA
    Neurotherapeutics; 2013 Oct; 10(4):789-97. PubMed ID: 23868468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.